Somatostatin messenger RNA in the antrum and corpus of rat stomach was quantified by Northern and slot blotting using a probe generated by the polymerase chain reaction. Fasting for 48 h enhanced the abundance of somatostatin mRNA in the pyloric antral region, but not in the acid-secreting region of the stomach. In fasted rats, somatostatin mRNA in antrum, but not corpus, was decreased by inhibition of acid secretion with omeprazole. In contrast, in rats treated with capsaicin to lesion small diameter afferents there was a significant decrease in somatostatin mRNA abundance in the corpus but not antrum. The effects of capsaicin cannot be attributed to nonspecific changes in gastric endocrine cell gene expression, since the abundance of histidine decarboxylase mRNA (which is a functionally regulated marker for a different gastric endocrine cell type) did not change with capsaicin. Gastric capsaicin-sensitive afferents are rich in calcitonin gene-related peptide, and in rats with antibodies to this peptide there was reduced corpus somatostatin mRNA. Moreover, infusion of calcitonin gene-related peptide in control rats produced a significant increase in somatostatin mRNA in the gastric corpus. The results indicate that somatostatin mRNA abundance is controlled by the gastric luminal contents and the extrinsic afferent innervation, but the relative importance of these factors differs in antrum and corpus: luminal contents are relatively more important in antrum and primary afferents using calcitonin gene-related peptide in the corpus. (J. Clin. Invest. 1993. 91:244-250.)
Introduction
The secretory functions of the gastric mucosa are regulated by the luminal contents of the stomach, and by humoral factors which include neurotransmitters such as acetylcholine, peptide hormones like gastrin, and paracrine regulators such as histamine and somatostatin ( 1 ). It is now thought that somatostatin acts locally in the antral mucosa to mediate the well known inhibitory effect of luminal acid on gastrin (G-) cell function (2) (3) (4) . However, somatostatin is also released by endocrine (D-) cells in the acid-secreting mucosa where it is thought to inhibit acid secretion at least in part by direct action on parietal cells (4) (5) (6) . The factors controlling gastric somatostatin release have been intensively studied in a variety of different preparations, including the perfused stomach and isolated D cells in short-term culture (3, (7) (8) (9) (10) . The available data indicate that in addition to luminal acid a number of peptides and neurotransmitters influence somatostatin release, among which is the neuropeptide calcitonin gene-related peptide (CGRP)' ( 1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . The latter is of interest, because it is localized exclusively to the primary afferent innervation of the stomach. Thus, > 80% ofgastric spinal afferents contain CGRP immunoreactivity compared with < 10% of vagal afferents; CGRP is absent from intrinsic gastric neurons in the rat, but is present in the peripheral terminals of afferents found in mucosa, submucosa, muscle layers, and myenteric plexus (14) (15) (16) (17) (18) .
Recent work suggests that the luminal contents ofthe stomach determine not only somatostatin release but also the abundance of somatostatin mRNA in the gastric mucosa. Brand and Stone ( 19) described reciprocal decreases in antral somatostatin and increases in gastrin mRNA abundance in rats treated with the H+/K+ ATPase inhibitor omeprazole; Wu et al. (20) also reported that reduction of acid secretion by fundectomy had similar effects. However, the factors controlling somatostatin mRNA abundance in the acid-secreting part ofthe stomach remain uncertain. We describe here the results of modulating the gastric luminal contents and of lesioning primary afferents on the abundance of somatostatin mRNA in corpus and antrum. The results are interesting in that they suggest differential control of somatostatin mRNA abundance in corpus and antrum, and identify CGRP released by small diameter (capsaicin-sensitive) primary afferent neurons as one of the influences regulating corpus mRNA levels.
Methods
Animals. The present studies were performed on female Wistar rats weighing 250 g. They were housed on a 12-h light-dark cycle. For experiments involving withdrawal of food, animals were kept in individual wire-bottomed cages and allowed access to water ad lib.
Experimental treatments. The relative importance of food and acid in the gastric lumen was determined by studies in experimental rats that were either fed ad lib. or fasted for 48 h. Both groups included rats that were treated with vehicle (0.25% wt/vol, methyl cellulose, 3 ml by gavage, at 0 and 24 h), or with omeprazole (400 ,mol/kg in vehicle, at 0 and 24 h). Animals were killed after 48 h and tissues taken as described below.
The role of small diameter primary afferent neurons was examined by studies in rats treated with the selective sensory neurotoxin, capsaicin. Neonatal rats (0-24-h old) were anesthetized with halothane and received capsaicin (50 mg/kg, subcutaneously in Tween:ethanol:water, 10:20:70) or vehicle. They were then reared normally. The success of the capsaicin-treatment was verified by the absence of an eye-wipe response to 0.1% (wt/vol) capsaicin when applied topically to adult animals.
The role of CGRP was examined using (a) immunoneutralization to block endogenous CGRP, and (b) by intravenous infusion ofexogenous peptide. The protocol used to generate neutralizing antibodies has previously been described (21 ) . In brief, experimental animals were induced to produce their own antibody by immunization with rat Tyro aCGRP28-37 conjugated to thyroglobulin by glutaraldehyde as described previously (21 ) . Animals received the equivalent of -25 nmol of peptide subcutaneously in CFA when their body weight was 100 g, and two further injections at 4-6-wk intervals of -12 nmol. Control rats were immunized with thyroglobulin alone. Blood samples were taken from a tail vein 7-10 d after the third immunization for monitoring ofantibody titres. Thereafter animals were taken for experiments as described below. The presence of circulating CGRP antibodies was verified by incubation of plasma in serial dilutions with 125I-labeled rat Tyro otCGRP28-37 as previously described ( 15, 21, 22) .
The action ofexogenous CGRP was examined by intravenous infusion in control and capsaicin-treated rats. Animals were anesthetized with pentobarbitone sodium (60 mg/kg) and an indwelling line established in the jugular vein and exteriorized at the back ofthe neck. The following day, animals were given intravenous infusions of either rat a-CGRP (1 nmol/kg per h) or saline, for 6 h. The animals were then killed and corpus taken for mRNA analysis.
Tissue extraction. Animals were killed by decapitation and trunk blood collected for radioimmunoassay of plasma gastrin which was used to monitor the effects of food deprivation and omeprazole treatment (23) . Plasma gastrin was determined using antibody L2 which is specific for the COOH terminus of heptadecapeptide gastrin (24) . The antral and corpus regions of the stomach were separately excised leaving behind a generous band of tissue at the antro-corpus border. A modification of the method of Chirgwin et al. (25) Corp., Arlington Heights, IL). After initial denaturation, 33 cycles of amplification (55°C for 1 min, 72°C for 2 min, 95°C for 1 min) were performed followed by a final extension cycle of 10 min at 72°C. The cDNA template used for these studies was generated from rat antral total RNA using a commercially available kit (Boehringer Mannheim Corp., Indianapolis, IN). Probes were purified on Qiagen-tip 5 mini columns (Diagen, Dusseldorf, Germany). In some experiments, gastrin, histidine decarboxylase (HDC), and fl actin mRNA's were studied using radiolabeled PCR products of 362 bp, 1,238 bp, and 644 bp, respectively, generated by inclusion of [ 32p] dCTP in the reaction mixture as previously described (23, 27) . Gel electrophoresis ofthe somatostatin PCR product and ofthe internally radiolabeled probe confirmed a size compatible with the predicted one of 464 bp, and digestion with PvuII generated products consistent with the predicted fragments of 289 and 164 bp (Fig. 1) .
DNA sequencing. Somatostatin PCR product was generated as described above, purified by Qiagen Tip-5 column, precipitated with isopropanol and the pellet dissolved in TE buffer. The concentration of DNA was estimated using a fluorometer (TKO 100; Hoefer Scientific Instruments, San Francisco, CA) and -1 pmol heated at 90°C for 3 min then snap frozen on dry ice/ethanol. Forward or reverse sequencing primer (i.e., sense or antisense PCR primer, 1 pmol) was added and the mixture annealed at room temperature for 30 min. Sequencing was performed using a T7 DNA sequencing kit (Promega Corp., Southampton, UK) according to standard protocols using [32P]dATP. Sequencing reactions were electrophoresed on 6% polyacrilamide gels, and the dried gels exposed to Kodak RP film for 48 h.
Northern blots and quantification. Withdrawal of food for 48 h produced a 486±94% increase in antral somatostatin mRNA abundance (P < 0.001 ), while gastrin mRNA abundance was reduced to 25.9±2.3% (P < 0.001 ) that in control rats fed ad lib. Both observations are in line with previous findings (23, 29) . Unexpectedly, however, we found that in the same rats, somatostatin mRNA abundance in the acid-secreting part of the stomach decreased on withdrawal of food to 63±18% of control. In both antrum and corpus there was a modest fall in , actin (to 81.4±6.9 and 74.2+4.9%, respectively) with fasting. It is known that treatment of rats with omeprazole reverses the fasting-induced reduction of gastrin mRNA (23) and decreases somatostatin mRNA in the antrum ( 19, 20) ; the same pattern ofresponses was observed here (Table I). In contrast, somatostatin mRNA in the acid secreting part of the stomach did not change when fasted rats were treated with omeprazole (Fig. 3 , Table I ). In rats fed ad lib., omeprazole increased antral gastrin mRNA as expected and decreased antral somatostatin mRNA; in addition, however, omeprazole treatment of fed rats also decreased somatostatin mRNA in the corpus (Table II) . The abundance of ( actin mRNA was unchanged in either region ofthe stomach by omeprazole (Tables I and II) . Capsaicin treatment and immunoneutralization. The results described above suggest that while the luminal contents of the stomach regulate somatostatin mRNA abundance, different mechanisms are at work in the corpus and the antrum.
Since CGRP stimulates somatostatin release, and is exclusively localized to the primary afferent innervation of the rat stomach, we investigated the role of these nerves in controlling somatostatin mRNA abundance. In rats that had been treated with capsaicin to lesion small diameter afferent neurons, corpus somatostatin mRNA was markedly depressed (P < 0.01 ) compared with vehicle-treated controls (Fig. 4) . In contrast, antral somatostatin abundance was unchanged. These changes were not attributable to nonspecific effects on corpus endocrine cell function because HDC mRNA, which is located in a different population ofcorpus mucosa endocrine cells, was unchanged by capsaicin treatment. Antral gastrin mRNA was also unaltered by capsaicin pretreatment.
The role ofCGRP was examined in rats that had been previously immunized to produce CGRP antibodies. The dilution of plasma from these rats required for binding of 50% of 2,000 cpm ofradiolabeled peptide in radioimmunoassay buffer (4°C, 24 h) varied from 1:2,700 to 1:13,000. In these rats somatostatin mRNA abundance in the corpus was depressed significantly (P < 0.025) (Fig. 5) . Again this was not a nonspecific effect because HDC mRNA abundance was unchanged (Fig. 6 ).
Direct evidence for the idea that CGRP increased somatostatin mRNA abundance was sought by intravenous infusion of the peptide. In control rats, a-CGRP infusion (1 nmol/kg per h) for 6 h produced a significant increase in somatostatin mRNA abundance in the corpus compared with saline-infused rats (saline: 100±7.0%, n = 4; CGRP: 158±14.7%, n = 6; P < 0.05). It was ofinterest that in parallel experiments in capsaicin-treated rats the infusion ofCGRP did not increase somatostatin mRNA abundance (saline: 100±4.8%, n = 5; CGRP: 97.8±7.3%, n = 6).
Discussion
The main finding of the present study is that separate factors determine the abundance of somatostatin mRNA in the acidsecreting part of the stomach, and in the antrum. The data therefore indicate that D cells of the antrum and corpus are functionally distinct. In fasted rats, the presence of gastric acid appears to be less important in maintaining corpus compared with antral somatostatin mRNA abundance. In contrast, small diameter primary afferent neurons appear to be important in maintaining corpus, but not antrum, somatostatin mRNA levels. These results extend earlier studies that have been directed at understanding the control of antral somatostatin mRNA levels ( 19, 20, 29) , and they draw attention to the primary afferent innervation of the stomach, and in particular to CGRP, as a factor determining gastric endocrine cell function.
Previous work by ourselves and others has shown that CGRP occurs in -80% of spinal afferent neurons projecting to the rat stomach, in < 10% of vagal gastric afferents, and is absent from gastric intrinsic neurons; CGRP is transported towards the peripheral terminals of spinal afferents that are located in the mucosa, around submucosal blood vessels, in circular smooth muscle and myenteric plexus (14) (15) (16) (17) (18) . In rats pretreated with the sensory neurotoxin capsaicin there is complete loss of gastric CGRP and of a high proportion of gastric Rats (n = 6 in each group) were fed ad lib., and received either vehicle or omeprazole (400 Amol/kg-', per os, 0 and 24 h). The effect of omeprazole is compared to the control group expressed as 100%. See text for further information. t test, * P < 0.05; § P < 0.01, tP < 0.001. (30) (31) (32) (33) (34) . It may well be that there are cooperative actions between CGRP and other afferent factors. Direct evidence for this comes from the observation that infusion of CGRP increases corpus somatostatin mRNA abundance in control but not in capsaicin-treated rats. It is plausible to suppose that in control rats CGRP increases somatostatin mRNA by interacting with some other factor, perhaps a tachykinin, produced by small diameter afferent neurons; whereas in capsaicin-treated rats, in which these factors are absent, the activity of CGRP is reduced correspondingly.
Control ofGastric
The changes in corpus somatostatin mRNA abundance with capsaicin pretreatment, and in the presence ofCGRP antibodies, can be considered specific since in the same circumstances there were no changes in gastrin and somatostatin mRNA in antrum, or for that matter in HDC mRNA which occurs in a different endocrine cell population (ECL cell) of the corpus mucosa. When the present observations are taken together with reports (a) that CGRP is a potent releaser of gastric somatostatin (1 1-13 (20, 40) . Changes in somatostatin mRNA abundance may not be directly reflected in changed tissue stores (20) ; it is however, clear that factors which influence gastric somatostatin mRNA are able to act over relatively short periods (29) , and that the same factors also rapidly influence somatostatin secretion (3, 12, 13, 35) supporting the idea that the two are functionally linked. 
